PASG News and Press, Passage Bio Inc. From 08/22/20

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Passage Bio, Inc. (PASG) Q2 2020 Earnings Conference Call August 13, 2020, 08:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Jill Quigley - COO Bruce Goldsmith - President and CEO Rich Morris - CFO Gary Romano - Chief Medical Officer Conference...

Passage Bio (NASDAQ: PASG ) : Q2 GAAP EPS of -$0.60 misses by $0.03 . More news on: Passage Bio, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

–  Submitted IND for PBGM01 Phase 1/2 trial; currently on FDA clinical hold pending additional review of proposed ICM delivery device – – Anticipate dosing first patient in PBGM01 Phase 1/2 trial in late 4Q2020 or early 1Q2021 – –  ...

PHILADELPHIA, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that it will host a conference call and live webcast at 8:30 a.m...